Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ; Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. NPJ Breast Cancer. 2021 Aug 3;7(1):102. doi: 10.1038/s41523-021-00306-9. PMID: 34344894; PMCID: PMC8333106.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- NPJ Breast Cancer
Literature Type
- PCORI Research